lobbying_activities: 627438

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
627438	856a04f1-918b-4fb0-b3ed-f66d065e3125	Q2	THE LIVINGSTON GROUP, LLC	49635	PKD FOUNDATION	2008	second_quarter	MED	Provide for research and clinical funding for PKD under the competitive Defense Peer Reviewed Medical Research Program under the FY 2009 Defense Appropriations bill (H.R. 3222 and Senate counterpart to be introduced); PKD report language to establish PKD Clinical and Diagnostic Treatment Centers in the NIH/NIDDK section of FY09 LHHS Approps bill (HR 3043:S. 1710); language to fund the expansion of PKD-specific patient services, education and empowerment initiatives that will support patient education, disease management and outreach in the HHS section of the FY 2009 Labor/HHS/Education Appropriations bill (H.R. 3043, S. 1710); passage of the entire Genetic Information Nondiscrimination Act of 2008 (HR 493; S 358); National PKD Awareness Week Resolution for 2008 to be introduced in the Senate; expansion of immunosuppressive drug coverage through the passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 (HR 3282, S 2030); passage of the entire Kidney Care Quality and Education Act of 2007 (HR 1193, S 691).	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2008-07-14T17:15:26-04:00